Poseida Therapeutics, Inc. Current Liabilities
Poseida Therapeutics, Inc. had Current Liabilities of $78.27 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2024-11-07
- 2024-09-30: Liabilities, Current $78.27M.
- 2024-06-30: Liabilities, Current $102.43M.
- 2024-03-31: Liabilities, Current $84.76M.
- 2023-12-31: Liabilities, Current $71.32M.
| Period end | Liabilities, Current |
|---|---|
| 2024-09-30 | $78.27M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $102.43M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $84.76M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $71.32M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $76.97M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $49.89M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $48.69M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $53.88M 10-K · filed 2024-03-07 |
| 2022-09-30 | $48.97M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $40.09M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $43.92M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $43.34M 10-K · filed 2023-03-09 |
| 2021-09-30 | $31.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $32.00M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $27.79M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $30.02M 10-K · filed 2022-03-10 |
| 2020-09-30 | $29.77M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $28.89M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $21.86M 10-K · filed 2021-03-11 |